| Note: This medical device record is a PMA supplement. A supplement may have changed the device description/function or indication from that approved in the original PMA. Be sure to look at the original PMA record for more information. |
| |
| Device | LIAISON® QuantiFERON®-TB Gold Plus II. |
| Generic Name | TEST, IMMUNITY, CELL MEDIATED, MYCOBACTERIUM TUBERCULOSIS |
| Applicant | DiaSorin, Inc. 1951 Northwestern Ave. Stillwater, MN 55082 |
| PMA Number | P180047 |
| Supplement Number | S046 |
| Date Received | 09/01/2026 |
| Decision Date | 09/24/2026 |
| Product Code |
NCD |
| Advisory Committee |
Microbiology |
| Supplement Type | 30-Day Notice |
| Supplement Reason | Process Change - Manufacturer/Sterilizer/Packager/Supplier |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement a manufacturing scale-up |
|
|